About Chronic Kidney Disease An estimated 26 million Americans and 50 million people worldwide have chronic kidney disease, or permanent kidney damage 10mg dose lipitor due to injury or disease. The global statin market appears poised for very strong growth, with worldwide sales of $25 billion in 2006, compared to the current market total 10mg dose lipitor of $14 billion. It was the largest study to date evaluating the efficacy and safety of Lipitor 80 mg. "There has been a good deal of discussion about achieving even lower LDL cholesterol goals especially in higher risk patients," said Christie Ballantyne, M. , director of the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center, Houston, Texas, and 10mg dose lipitor lead investigator of the study. What’s driving the market Aging population: By 2006 there will be 37 million senior 10mg dose lipitor citizens in the U. , of whom 40 percent will be at risk of developing hyperlipidemia. There were no clinically or statistically significant differences in the incidence of muscle enzyme elevations and no patients in the study were diagnosed with myopathy. > Pfizer announced that it had received FDA approval for higher starting doses for Lipitor. VYTORIN is a prescription medicine and should not be taken by people who are hypersensitive to any of its components. New therapies and broader indications: More potent LDL therapies that may require less titration, as well as products that also improve HDL levels and target such other indications as inflammation, are also expected to expand the market. A Pfizer doctor said that the data was still fairly limited, and it appears to show only minimal difference 10mg dose lipitor in efficacy between the two drugs. "In this study, VYTORIN was significantly more effective than Lipitor in reducing LDL cholesterol at all doses compared and for attaining LDL cholesterol treatment goals pooled across the dosing range," said Christie Ballantyne, M. , director of the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center, Houston, Texas, and lead investigator of the study. When diet and exercise alone are not enough, Lipitor is used along with a low-fat diet and exercise to lower cholesterol. However, the great majority said they were likely, somewhat likely, or very likely to try Crestor for their new patients; only about 10 percent said they were not at all likely to do so. Emphasis on earlier and more aggressive treatment: This is especially true of 10mg dose lipitor moderateto high-risk patients. This sub-analysis studied 3,107 patients with moderate to severe chronic kidney disease, as defined using a standard measure of kidney function. What the doctors say Our projections are based in large part on what the physicians 10mg dose lipitor in our panel told us they expected to do once Crestor is launched. The recommended starting dose of VYTORIN is 10/20 mg (10 mg ezetimibe/20 mg simvastatin). Lipitor is also used in patients with type 2 diabetes and at least one other risk factor for heart disease such as high blood pressure, smoking or complications of diabetes, including eye disease and protein in urine, to reduce the risk of heart attack and stroke. All three of our approaches led to the same basic conclusions as to both the growth of the overall statin market (see Exhibit 1, page 142) and the relative strengths of the leading products once Crestor enters the fray. Lipitor is 10mg dose lipitor not for everyone. There were no clinically or statistically significant differences in the incidence of muscle enzyme elevations and no patients in the study were diagnosed with myopathy. New data from the Treating to New Targets (TNT) study suggest that treating patients with confirmed coronary heart disease to below current cholesterol target levels significantly reduces deaths from heart attacks and strokes.